Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice
Open Access
- 3 January 2018
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 2 (1) , 25-35
Abstract
Key Points: FXIIIplasma, but not FXIIIplt, promotes RBC retention in thrombi and increases thrombus weight. Partial FXIII reduction may reduce venous thrombosis.Keywords
This publication has 50 references indexed in Scilit:
- The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathwaysBlood, 2012
- Factor XIII and inflammatory cellsThrombosis Research, 2012
- The antifibrinolytic function of factor XIII is exclusively expressed through α2-antiplasmin cross-linkingBlood, 2011
- The heparin-binding exosite of factor IXa is a critical regulator of plasma thrombin generation and venous thrombosisBlood, 2008
- Type‐2 plasminogen‐activator inhibitor is a substrate for trophoblast transglutaminase and Factor XIIIaEuropean Journal of Biochemistry, 1993
- A familial factor XIII subunit B deficiencyBritish Journal of Haematology, 1990
- Platelet vinculin: a substrate of activated Factor XIIIBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1988
- Rapid formation of large molecular weight alpha-polymers in cross-linked fibrin induced by high factor XIII concentrations. Role of platelet factor XIII.Journal of Clinical Investigation, 1987
- On the Retraction of Collagen and Fibrin Induced by Normal, Defective and Modified PlateletsPathophysiology of Haemostasis and Thrombosis, 1985
- Clot Retraction in a Factor XIII Free SystemScandinavian Journal of Haematology, 1980